{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:31:40Z","timestamp":1791318700192,"version":"4.3.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["arthroplastyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Arthroplasty"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.arth.2022.03.072","type":"journal-article","created":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T21:11:51Z","timestamp":1648242711000},"page":"1650-1657","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["The Use of Rifampin in Total Joint Arthroplasty: A Systematic Review and Meta-Analysis of Comparative Studies"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3871-1567","authenticated-orcid":false,"given":"Colin C.","family":"Kruse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seper","family":"Ekhtiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismet","family":"Oral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9382-1606","authenticated-orcid":false,"given":"Asher","family":"Selznick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raman","family":"Mundi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harman","family":"Chaudhry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Pincus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3013-2437","authenticated-orcid":false,"given":"Jesse","family":"Wolfstadt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher E.","family":"Kandel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arth.2022.03.072_bib1","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.arth.2007.10.017","article-title":"Infection burden for hip and knee arthroplasty in the United States","volume":"23","author":"Kurtz","year":"2008","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2022.03.072_bib2","doi-asserted-by":"crossref","first-page":"780","DOI":"10.2106\/00004623-200704000-00012","article-title":"Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030","volume":"89","author":"Kurtz","year":"2007","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2022.03.072_bib3","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1016\/j.arth.2021.02.051","article-title":"The changing characteristics of arthroplasty patients: a retrospective cohort study","volume":"36","author":"Ekhtiari","year":"2021","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2022.03.072_bib4","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1017\/ice.2018.199","article-title":"The cost of managing complex surgical site infections following primary hip and knee arthroplasty: a population-based cohort study in Alberta, Canada","volume":"39","author":"Rennert-May","year":"2018","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.arth.2022.03.072_bib5","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.arth.2020.12.005","article-title":"Projected economic burden of periprosthetic joint infection of the hip and knee in the United States","volume":"36","author":"Premkumar","year":"2021","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2022.03.072_bib6","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1128\/CMR.00111-13","article-title":"Prosthetic joint infection","volume":"27","author":"Tande","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.arth.2022.03.072_bib7","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/cis803","article-title":"Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the infectious diseases Society of America","volume":"56","author":"Osmon","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.arth.2022.03.072_bib8","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/jac\/dkp469","article-title":"Two-stage revision for prosthetic joint infection: predictors of outcome and the role of reimplantation microbiology","volume":"65","author":"Bejon","year":"2010","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.arth.2022.03.072_bib9","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s11999-010-1434-1","article-title":"The chitranjan ranawat award: fate of two-stage reimplantation after failed irrigation and d\u00e9bridement for periprosthetic knee infection","volume":"469","author":"Sherrell","year":"2011","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.arth.2022.03.072_bib10","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13018-016-0428-4","article-title":"Eradication rates, risk factors, and implant selection in two-stage revision knee arthroplasty: a mid-term follow-up study","volume":"11","author":"Hoell","year":"2016","journal-title":"J\u00a0Orthop Surg Res"},{"key":"10.1016\/j.arth.2022.03.072_bib11","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1007\/s11999-010-1338-0","article-title":"Prior use of antimicrobial therapy is a risk factor for culture-negative prosthetic joint infection","volume":"468","author":"Malekzadeh","year":"2010","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.arth.2022.03.072_bib12","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/ofid\/ofz452","article-title":"Predictors of treatment failure for hip and knee prosthetic joint infections in the setting of 1-and 2-stage exchange arthroplasty: a multicenter retrospective cohort","volume":"6","author":"Kandel","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.arth.2022.03.072_bib13","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4161\/viru.2.5.17724","article-title":"Staphylococcus aureus biofilms: properties, regulation and roles in human disease","volume":"2","author":"Archer","year":"2011","journal-title":"Virulence"},{"key":"10.1016\/j.arth.2022.03.072_bib14","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/cid\/cir402","article-title":"Outcome and predictors of treatment failure in total hip\/knee prosthetic joint infections due to Staphylococcus aureus","volume":"53","author":"Senneville","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.arth.2022.03.072_bib15","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1128\/CMR.00034-09","article-title":"Rifampin combination therapy for nonmycobacterial infections","volume":"23","author":"Forrest","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.arth.2022.03.072_bib16","first-page":"7714","article-title":"Rifampicin combined with levofloxacin for preventing infection after total hip arthroplasty","volume":"48","author":"Li","year":"2014","journal-title":"Chin J Tissue Eng Res"},{"key":"10.1016\/j.arth.2022.03.072_bib17","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1001\/jama.279.19.1537","article-title":"Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial","volume":"279","author":"Zimmerli","year":"1998","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.arth.2022.03.072_bib18","series-title":"Cochrane handbook for systematic reviews of interventions version 6.0","author":"Higgins","year":"2019"},{"key":"10.1016\/j.arth.2022.03.072_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.arth.2022.03.072_bib20","doi-asserted-by":"crossref","first-page":"I4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.arth.2022.03.072_bib21","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1046\/j.1445-2197.2003.02748.x","article-title":"Methodological index for non-randomized studies (MINORS): development and validation of a new instrument","volume":"73","author":"Slim","year":"2003","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.arth.2022.03.072_bib22","series-title":"Review manager (RevMan)","year":"2014"},{"key":"10.1016\/j.arth.2022.03.072_bib23","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1302\/0301-620X.99B5.BJJ-2016-0851.R1","article-title":"High failure rates in treatment of streptococcal periprosthetic joint infection: results from a seven-year retrospective cohort study","volume":"99-B","author":"Akg\u00fcn","year":"2017","journal-title":"Bone Joint J"},{"key":"10.1016\/j.arth.2022.03.072_bib24","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3109\/17453674.2015.1026756","article-title":"75% success rate after open debridement, exchange of tibial insert, and antibiotics in knee prosthetic joint infections","volume":"86","author":"Holmberg","year":"2015","journal-title":"Acta Orthop"},{"key":"10.1016\/j.arth.2022.03.072_bib25","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3109\/17453674.2015.1094613","article-title":"Treatment of prosthetic joint infections due to Propionibacterium. Similar results in 60 patients treated with and without rifampicin","volume":"87","author":"Jacobs","year":"2016","journal-title":"Acta Orthop"},{"key":"10.1016\/j.arth.2022.03.072_bib26","doi-asserted-by":"crossref","first-page":"e1064","DOI":"10.1093\/cid\/ciaa1839","article-title":"The impact of surgical strategy and rifampin on treatment outcome in Cutibacterium periprosthetic joint infections","volume":"72","author":"Kusejko","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.arth.2022.03.072_bib27","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1007\/s10096-018-3330-7","article-title":"Should we expand the indications for the DAIR (debridement, antibiotic therapy, and implant retention) procedure for Staphylococcus aureus prosthetic joint infections? A multicenter retrospective study","volume":"37","author":"Lesens","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.arth.2022.03.072_bib28","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/cid\/cis746","article-title":"A large multicenter study of methicillin-susceptible and methicillin-resistant Staphylococcus aureus prosthetic joint infections managed with implant retention","volume":"56","author":"Lora-Tamayo","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.arth.2022.03.072_bib29","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1093\/cid\/cix227","article-title":"The not-so-good prognosis of streptococcal periprosthetic joint infection managed by implant retention: the results of a large multicenter study","volume":"64","author":"Lora-Tamayo","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.arth.2022.03.072_bib30","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijid.2019.06.012","article-title":"The prognosis of streptococcal prosthetic bone and joint infections depends on surgical management\u2014a multicenter retrospective study","volume":"85","author":"Mahieu","year":"2019","journal-title":"Int J Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.arth.2022.03.072_bib31","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1093\/ofid\/ofy210.324","article-title":"313. Outpatient treatment and recurrence of prosthetic joint infection (PJI) in infectious disease (ID) physician office infusion centers (POICs): a 2-year retrospective multicenter analysis","volume":"5","author":"Metzger","year":"2018","journal-title":"Open Forum Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.arth.2022.03.072_bib32","article-title":"Two-year outcomes of infected total hip arthroplasty treated with debridement and implant retention","volume":"3","author":"Miller","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.arth.2022.03.072_bib33","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s40121-014-0032-z","article-title":"A retrospective review of the clinical experience of linezolid with or without rifampicin in prosthetic joint infections treated with debridement and implant retention","volume":"3","author":"Morata","year":"2014","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.arth.2022.03.072_bib34","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00264-020-04722-7","article-title":"Factors affecting outcome in the treatment of streptococcal periprosthetic joint infections: results from a single-centre retrospective cohort study","volume":"45","author":"Andronic","year":"2021","journal-title":"Int Orthop"},{"key":"10.1016\/j.arth.2022.03.072_bib35","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/j.1469-0691.2009.02761.x","article-title":"Efficacy and tolerance of rifampicin-linezolid compared with rifampicin-cotrimoxazole combinations in prolonged oral therapy for bone and joint infections","volume":"15","author":"Nguyen","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.arth.2022.03.072_bib36","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1007\/s00264-015-2819-2","article-title":"Predictors of treatment outcome in prosthetic joint infections treated with prosthesis retention","volume":"39","author":"Puhto","year":"2015","journal-title":"Int Orthop"},{"key":"10.1016\/j.arth.2022.03.072_bib37","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12879-021-05832-2","article-title":"Impact of rifampicin dose in bone and joint prosthetic device infections due to Staphylococcus spp: a retrospective single-center study in France","volume":"21","author":"Tonnelier","year":"2021","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.arth.2022.03.072_bib38","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1093\/jac\/dkv481","article-title":"Importance of selection and duration of antibiotic regimen in prosthetic joint infections treated with debridement and implant retention","volume":"71","author":"Tornero","year":"2016","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.arth.2022.03.072_bib39","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ijantimicag.2017.04.011","article-title":"Moxifloxacin plus rifampin as an alternative for levofloxacin plus rifampin in the treatment of a prosthetic joint infection with Staphylococcus aureus","volume":"51","author":"Wouthuyzen-Bakker","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.arth.2022.03.072_bib40","first-page":"40","article-title":"Clinical outcome and risk factors for failure in late acute prosthetic joint infections treated with debridement and implant retention","volume":"78","author":"Wouthuyzen-Bakker","year":"2019","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.arth.2022.03.072_bib41","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1016\/j.arth.2017.02.057","article-title":"Oral therapy, microbiological findings, and comorbidity influence the outcome of prosthetic joint infections undergoing 2-stage exchange","volume":"32","author":"Ascione","year":"2017","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2022.03.072_bib42","doi-asserted-by":"crossref","first-page":"28","DOI":"10.7150\/jbji.40333","article-title":"Duration of rifampin therapy is a key determinant of improved outcomes in early-onset acute prosthetic joint infection due to Staphylococcus treated with a debridement, antibiotics and implant retention (DAIR): a retrospective multicenter study in France","volume":"5","author":"Becker","year":"2020","journal-title":"J\u00a0Bone Joint Infect"},{"key":"10.1016\/j.arth.2022.03.072_bib43","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/cid\/ciab426","article-title":"If, when, and how to use rifampin in acute staphylococcal periprosthetic joint infections, a multicentre observational study","volume":"73","author":"Beldman","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.arth.2022.03.072_bib44","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.medmal.2017.09.016","article-title":"Non-compliance with IDSA guidelines for patients presenting with methicillin-susceptible Staphylococcus aureus prosthetic joint infection is a risk factor for treatment failure","volume":"48","author":"Bouaziz","year":"2018","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.arth.2022.03.072_bib45","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijid.2017.08.002","article-title":"Antibiotic therapy duration for prosthetic joint infections treated by debridement and implant retention (DAIR): similar long-term remission for 6 weeks as compared to 12 weeks","volume":"63","author":"Chaussade","year":"2017","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.arth.2022.03.072_bib46","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s10096-010-0952-9","article-title":"Efficacy and safety of rifampin containing regimen for staphylococcal prosthetic joint infections treated with debridement and retention","volume":"29","author":"El Helou","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.arth.2022.03.072_bib47","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3390\/antibiotics10020118","article-title":"Implant removal in the management of prosthetic joint infection by Staphylococcus aureus: outcome and predictors of failure in a large retrospective multicenter study","volume":"10","author":"G\u00f3mez-Junyent","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.arth.2022.03.072_bib48","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1093\/cid\/ciw665","article-title":"A randomized study evaluating oral fusidic acid (CEM-102) in combination with oral rifampin compared with standard-of-care antibiotics for treatment of prosthetic joint infections: a newly identified drug-drug interaction","volume":"63","author":"Pushkin","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.arth.2022.03.072_bib49","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/s13018-020-01877-2","article-title":"Rifampin combination therapy in staphylococcal prosthetic joint infections: a randomized controlled trial","volume":"15","author":"Karlsen","year":"2020","journal-title":"J\u00a0Orthop Surg Res"},{"key":"10.1016\/j.arth.2022.03.072_bib50","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ijantimicag.2016.05.021","article-title":"Short- versus long-duration levofloxacin plus rifampicin for acute staphylococcal prosthetic joint infection managed with implant retention: a randomised clinical trial","volume":"48","author":"Lora-Tamayo","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.arth.2022.03.072_bib51","first-page":"30","article-title":"Factors related to outcome of early and delayed prosthetic joint infections","volume":"70","author":"Ascione","year":"2015","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.arth.2022.03.072_bib52","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa344","article-title":"Genotypic and phenotypic characteristics of Staphylococcus aureus prosthetic joint infections: insight on the pathogenesis and prognosis of a multicenter prospective cohort","volume":"7","author":"Mu\u00f1oz-Gallego","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.arth.2022.03.072_bib53","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1001\/archinte.168.8.805","article-title":"Adjunctive use of rifampin for the treatment of Staphylococcus aureus infections","volume":"168","author":"Perlroth","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.arth.2022.03.072_bib54","doi-asserted-by":"crossref","first-page":"982","DOI":"10.2174\/1389450120666190405095712","article-title":"Current understanding of group A streptococcal biofilms","volume":"20","author":"Vyas","year":"2019","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.arth.2022.03.072_bib55","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.ijmm.2018.09.005","article-title":"Comparative analyses of biofilm formation among different Cutibacterium acnes isolates","volume":"308","author":"Kuehnast","year":"2018","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.arth.2022.03.072_bib56","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1016\/j.arth.2018.06.015","article-title":"Defining treatment success after 2-stage exchange arthroplasty for periprosthetic joint infection","volume":"33","author":"Tan","year":"2018","journal-title":"J\u00a0Arthroplasty"}],"container-title":["The Journal of Arthroplasty"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540322003746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540322003746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:40:19Z","timestamp":1760121619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883540322003746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":56,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0883540322003746"],"URL":"https:\/\/doi.org\/10.1016\/j.arth.2022.03.072","relation":{},"ISSN":["0883-5403"],"issn-type":[{"value":"0883-5403","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Use of Rifampin in Total Joint Arthroplasty: A Systematic Review and Meta-Analysis of Comparative Studies","name":"articletitle","label":"Article Title"},{"value":"The Journal of Arthroplasty","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arth.2022.03.072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}